ShareD-BD: Shared Medical Decision Making in the Prophylactic Treatment of Bipolar Disorder

Sponsor
Centre Hospitalier Universitaire de Nīmes (Other)
Overall Status
Recruiting
CT.gov ID
NCT03245593
Collaborator
(none)
300
14
71.3
21.4
0.3

Study Details

Study Description

Brief Summary

The investigators hypothesize that implementation of a shared decision making care plan for prophylactic treatment will help therapeutic adherence of bipolar patients. They also anticipate that patients treated according to a shared decision making plan will have an elevated satisfaction of their care, quality of life and functionment, as well as a lower number of relapses

Condition or Disease Intervention/Treatment Phase
  • Other: Shared-decision making process
  • Other: standard care

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Shared Medical Decision Making in the Prophylactic Treatment of Bipolar Disorder
Actual Study Start Date :
Apr 24, 2018
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Shared Decision making for care

Other: Shared-decision making process
Completion of the Ottawa Personal Decision Guide to help guide care with the support of online and printed material describing the therapeutic options available

Standard decision making for care

Other: standard care
Care of patients according to standard practice of managing patients with bipolar disorder

Outcome Measures

Primary Outcome Measures

  1. Measure the difference of prophylactic treatment compliance between bipolar patients receiving treatment according to standard care versus a shared decision making care plan following a mood episode. [12 months]

    Clinician Rating Scale (1-7)

Secondary Outcome Measures

  1. Study the clinician-reported difference between the 2 groups in medication adherence [3 months]

    Clinician Rating Scale (1-7)

  2. Study the clinician-reported difference between the 2 groups in medication adherence [6 months]

    Clinician Rating Scale (1-7)

  3. Study the clinician-reported difference between the 2 groups in medication adherence [9 months]

    Clinician Rating Scale (1-7)

  4. Study the self-reported difference between the 2 groups in medication adherence [3 months]

    Medication Adherence Rating Scale( 0-10),

  5. Study the self-reported difference between the 2 groups in medication adherence [6 months]

    Medication Adherence Rating Scale( 0-10),

  6. Study the self-reported difference between the 2 groups in medication adherence [9 months]

    Medication Adherence Rating Scale( 0-10),

  7. Study the self-reported difference between the 2 groups in medication adherence [12 months]

    Medication Adherence Rating Scale( 0-10),

  8. Clinical evaluation of the difference between the 2 groups in medication adherence [3 months]

    Plasma levels of medication for treatment of bipolar disorder, Lithium, anticonvulsants, second generation antipsychotics and antidepressants

  9. Clinical evaluation of the difference between the 2 groups in medication adherence [6 months]

    Plasma levels of medication for treatment of bipolar disorder, Lithium, anticonvulsants, second generation antipsychotics and antidepressants

  10. Clinical evaluation of the difference between the 2 groups in medication adherence [9 months]

    Plasma levels of medication for treatment of bipolar disorder, Lithium, anticonvulsants, second generation antipsychotics and antidepressants

  11. Clinical evaluation of the difference between the 2 groups in medication adherence [12 months]

    Plasma levels of medication for treatment of bipolar disorder, Lithium, anticonvulsants, second generation antipsychotics and antidepressants

  12. Compare difference in the adherence to personalized follow-up between groups [3 months]

    percentage of consultations missed

  13. Compare difference in the adherence to personalized follow-up between groups [6 months]

    percentage of consultations missed

  14. Compare difference in the adherence to personalized follow-up between groups [9 months]

    percentage of consultations missed

  15. Compare difference in the adherence to personalized follow-up between groups [12 months]

    percentage of consultations missed

  16. Compare difference in patient perceptions related to the uncertainty of the medical decisions taken between groups [3 months]

    decisional conflict scale (0-100)

  17. Compare difference in patient perceptions related to the uncertainty of the medical decisions taken between groups [6 months]

    decisional conflict scale (0-100)

  18. Compare difference in patient perceptions related to the uncertainty of the medical decisions taken between groups [9 months]

    decisional conflict scale (0-100)

  19. Compare difference in patient perceptions related to the uncertainty of the medical decisions taken between groups [12 months]

    decisional conflict scale (0-100)

  20. Compare difference in patient satisfaction concerning the therapeutic decisions taken between groups [3 months]

    adapted QSH-45: 3 questions scored 1-5

  21. Compare difference in patient satisfaction concerning the therapeutic decisions taken between groups [6 months]

    adapted QSH-45: 3 questions scored 1-5

  22. Compare difference in patient satisfaction concerning the therapeutic decisions taken between groups [9 months]

    adapted QSH-45: 3 questions scored 1-5

  23. Compare difference in patient satisfaction concerning the therapeutic decisions taken between groups [12 months]

    adapted QSH-45: 3 questions scored 1-5

  24. Compare difference in patient satisfaction concerning the decision-making process between groups [3 months]

    Adapted clinical decision making involvement and satisfaction score 3 questions scored 1-5

  25. Compare difference in patient satisfaction concerning the decision-making process between groups [6 months]

    Adapted clinical decision making involvement and satisfaction score 3 questions scored 1-5

  26. Compare difference in patient satisfaction concerning the decision-making process between groups [9 months]

    Adapted clinical decision making involvement and satisfaction score 3 questions scored 1-5

  27. Compare difference in patient satisfaction concerning the decision-making process between groups [12 months]

    Adapted clinical decision making involvement and satisfaction score 3 questions scored 1-5

  28. Compare difference in therapeutic alliance between groups [3 months]

    4-Point ordinal Alliance Scale

  29. Compare difference in therapeutic alliance between groups [6 months]

    4-Point ordinal Alliance Scale

  30. Compare difference in therapeutic alliance between groups [9 months]

    4-Point ordinal Alliance Scale

  31. Compare difference in therapeutic alliance between groups [12 months]

    4-Point ordinal Alliance Scale

  32. Compare difference in knowledge of disease and treatment necessary to making decisions between groups [3 months]

    Knowledge questionnaire: % correct answers

  33. Compare difference in knowledge of disease and treatment necessary to making decisions between groups [6 months]

    Knowledge questionnaire: % correct answers

  34. Compare difference in knowledge of disease and treatment necessary to making decisions between groups [9 months]

    Knowledge questionnaire: % correct answers

  35. Compare difference in knowledge of disease and treatment necessary to making decisions between groups [12 months]

    Knowledge questionnaire: % correct answers

  36. Compare difference in patient attitude towards the treatment between groups [3 months]

    Beliefs about Medicines Questionnaire: 18 questions 1-5

  37. Compare difference in patient attitude towards the treatment between groups [6 months]

    Beliefs about Medicines Questionnaire: 18 questions 1-5

  38. Compare difference in patient attitude towards the treatment between groups [9 months]

    Beliefs about Medicines Questionnaire: 18 questions 1-5

  39. Compare difference in patient attitude towards the treatment between groups [12 months]

    Beliefs about Medicines Questionnaire: 18 questions 1-5

  40. Compare number and duration of mood episodes between groups months [3 months]

    number of events; number of days

  41. Compare number and duration of mood episodes between groups months [6 months]

    number of events; number of days

  42. Compare number and duration of mood episodes between groups months [9 months]

    number of events; number of days

  43. Compare number and duration of mood episodes between groups months [12 months]

    number of events; number of days

  44. Compare number and duration of hospitalizations in psychiatric service between groups [3 months]

    number of events; number of days

  45. Compare number and duration of hospitalizations in psychiatric service between groups [6 months]

    number of events; number of days

  46. Compare number and duration of hospitalizations in psychiatric service between groups [9 months]

    number of events; number of days

  47. Compare number and duration of hospitalizations in psychiatric service between groups [12 months]

    number of events; number of days

  48. Compare manic symptomatology during evaluations between groups [3 months]

    Young Mania Rating Scale

  49. Compare manic symptomatology during evaluations between groups [6 months]

    Young Mania Rating Scale

  50. Compare manic symptomatology during evaluations between groups [9 months]

    Young Mania Rating Scale

  51. Compare manic symptomatology during evaluations between groups [12 months]

    Young Mania Rating Scale

  52. Compare the depressive symptomatology during evaluations between groups [3 months]

    Montgomery-Asberg Depression Rating Scale

  53. Compare the depressive symptomatology during evaluations between groups [6 months]

    Montgomery-Asberg Depression Rating Scale

  54. Compare the depressive symptomatology during evaluations between groups [9 months]

    Montgomery-Asberg Depression Rating Scale

  55. Compare the depressive symptomatology during evaluations between groups [12 months]

    Montgomery-Asberg Depression Rating Scale

  56. Compare severity and intensity of suicidal ideas between groups [3 months]

    Columbia-Suicide Severity Rating Scale

  57. Compare severity and intensity of suicidal ideas between groups [6 months]

    Columbia-Suicide Severity Rating Scale

  58. Compare severity and intensity of suicidal ideas between groups [9 months]

    Columbia-Suicide Severity Rating Scale

  59. Compare severity and intensity of suicidal ideas between groups [12 months]

    Columbia-Suicide Severity Rating Scale

  60. Compare the psychosocial functioning between groups [3 months]

    Functioning Assessment Short Test (0-72)

  61. Compare the psychosocial functioning between groups [6 months]

    Functioning Assessment Short Test (0-72)

  62. Compare the psychosocial functioning between groups [9 months]

    Functioning Assessment Short Test (0-72)

  63. Compare the psychosocial functioning between groups [12 months]

    Functioning Assessment Short Test (0-72)

  64. Compare quality of life between groups [3 months]

    WHOQOL-BREF (0-100)

  65. Compare quality of life between groups [6 months]

    WHOQOL-BREF (0-100)

  66. Compare quality of life between groups [9 months]

    WHOQOL-BREF (0-100)

  67. Compare quality of life between groups [12 months]

    WHOQOL-BREF (0-100)

  68. Compare length of consultations between groups [every consultation for 12 months]

    minutes

  69. Clinician satisfaction concerning the therapeutic decisions taken between groups [3 months]

    adapted QSH-45 doctor version 3 questions scored 1-5

  70. Clinician satisfaction concerning the therapeutic decisions taken between groups [6 months]

    adapted QSH-45 doctor version 3 questions scored 1-5

  71. Clinician satisfaction concerning the therapeutic decisions taken between groups [9 months]

    adapted QSH-45 doctor version 3 questions scored 1-5

  72. Clinician satisfaction concerning the therapeutic decisions taken between groups [12 months]

    adapted QSH-45 doctor version 3 questions scored 1-5

  73. Clinician satisfaction concerning the decision-making process between groups [3 months]

    Adapted clinical decision making involvement and satisfaction score doctor version 3: questions scored 1-5

  74. Clinician satisfaction concerning the decision-making process between groups [6 months]

    Adapted clinical decision making involvement and satisfaction score doctor version 3: questions scored 1-5

  75. Clinician satisfaction concerning the decision-making process between groups [9 months]

    Adapted clinical decision making involvement and satisfaction score doctor version 3: questions scored 1-5

  76. Clinician satisfaction concerning the decision-making process between groups [12 months]

    Adapted clinical decision making involvement and satisfaction score doctor version 3: questions scored 1-5

  77. Clinician perceptions related to the uncertainty of the medical decisions taken between groups [3 months]

    decisional conflict scale doctor version (0-100)

  78. Clinician perceptions related to the uncertainty of the medical decisions taken between groups [6 months]

    decisional conflict scale doctor version (0-100)

  79. Clinician perceptions related to the uncertainty of the medical decisions taken between groups [9 months]

    decisional conflict scale doctor version (0-100)

  80. Clinician perceptions related to the uncertainty of the medical decisions taken between groups [12 months]

    decisional conflict scale doctor version (0-100)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • The patient must have given their free and informed consent and signed the consent form

  • The patient must be a member or beneficiary of a health insurance plan

  • The patient must be available for the 12 months of follow-up

  • The patient is at least 18 years old

  • Patients is suffering from bipolar disorder (I or II) according to DSM-5 criteria

  • Following resolution of a mood episode (manic or depressive according to DSM-5 criteria) according to the criteria of l'International Society for Bipolar Disorder (Recovery, clinical remission of at least 4 weeks)

  • Followed by at least one of the practitioner belonging to one of the participating centers

  • Without comprehension problems of fluent French

Exclusion Criteria:
  • The subject is participating in an interventional study, or has participated in another interventional study within the previous 3 months

  • The subject is in a period of exclusion determined by a previous study

  • The patient is under safeguard of justice or state guardianship

  • It is impossible to give the subject informed information, or the subject refuses to sign the consent

  • The subject has already participated in this study

  • The patient has troubles linked to the usage of severe intensive substances (such as those defined by the DMS-5)

  • The patient has a revision of the initial diagnosis of bipolar disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 CH Charles Perrens Bordeaux France 33076
2 CH le Vinatier Bron France 69678
3 CHU de Clermont Ferrand - Hôpital Gabriel-Montpied Clermont-Ferrand France 63003
4 CH Sainte-Marie de Clermont-Ferrand Clermont-Ferrand France 63037
5 APHP - Centre Hospitalier Henri Mondor Créteil France 94010
6 CHU de Grenoble - Hôpital Albert Michallon Grenoble France 38043
7 CH Limoges Limoges France 87025
8 APHM - Hôpital Sainte-Marguerite Marseille France 13274
9 CHU de Montpellier - Hôpital Lapeyronie Montpellier France 34295
10 CHU Nancy Nancy France 54000
11 CHU Nantes Nantes France 44000
12 Clinique des troubles thymiques Nîmes France 30000
13 CHU Nimes Nîmes France 30029
14 APHP - Hôpital Saint Louis-Lariboisière-Fernand-Widal Paris France 75475

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Nīmes

Investigators

  • Principal Investigator: Ludovic Samalin, University Hospital, Clermont-Ferrand

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Nīmes
ClinicalTrials.gov Identifier:
NCT03245593
Other Study ID Numbers:
  • PREPS/2016/LS-01
First Posted:
Aug 10, 2017
Last Update Posted:
Jan 19, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 19, 2022